PCT/2002/18 - World Intellectual Property Organization
PCT/2002/18 - World Intellectual Property Organization
PCT/2002/18 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>18</strong>/<strong>2002</strong><br />
2 May/mai <strong>2002</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 8559<br />
Erwin, Paul [AT/AT]; Anton Baumgartner<br />
Strasse 125/4/02, A-1230 Vienna (AT).<br />
WOLFF-WINISKI, Barbara [DE/AT];<br />
Maurer Lange Gasse 137/9, A-1238 Vienna<br />
(AT).<br />
(74) BECKER, Konrad; Novartis AG, Corporate<br />
<strong>Intellectual</strong> <strong>Property</strong>, Patent & Trademark Department,<br />
CH-4002 Basel (CH).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/20, 31/33, A61P 31/<strong>18</strong> // (A61K<br />
38/20, 31:33)<br />
(11) WO 02/34284 (13) A2<br />
(21) <strong>PCT</strong>/US01/31903<br />
(22) 11 Oct/oct 2001 (11.10.2001)<br />
(25) en (26) en<br />
(30) 60/242,090 20 Oct/oct 2000 US<br />
(20.10.2000)<br />
(43) 2 May/mai <strong>2002</strong> (02.05.<strong>2002</strong>)<br />
(54) METHODS OF THERAPY FOR HIV IN-<br />
FECTION<br />
PROCEDES DE TRAITEMENT DE<br />
L’INFECTION PAR LE VIH<br />
(71) CHIRON CORPORATION [US/US]; 4560<br />
Horton Street, Emeryville, CA 94608-2916<br />
(US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) SAHNER, David [US/US]; 1607 Berkeley<br />
Way, Berkeley, CA 94703 (US).<br />
(74) LAUNER, Charlene, A.; Chiron Corporation,<br />
<strong>Intellectual</strong> <strong>Property</strong> -R338, P.O. Box<br />
8097, Emeryville, CA 94662-8097 (US) et al.<br />
/ etc.<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/26, A61P 9/10<br />
(11) WO 02/34285 (13) A2<br />
(21) <strong>PCT</strong>/US01/32559<br />
(22) 22 Oct/oct 2001 (22.10.2001)<br />
(25) en (26) en<br />
(30) 60/241,834 20 Oct/oct 2000<br />
(20.10.2000)<br />
US<br />
(30) 60/242,139 23 Oct/oct 2000 US<br />
(23.10.2000)<br />
(30) 60/245,234 3 Nov/nov 2000 US<br />
(03.11.2000)<br />
(43) 2 May/mai <strong>2002</strong> (02.05.<strong>2002</strong>)<br />
(54) TREATMENT OF HIBERNATING MY-<br />
OCARDIUM AND DIABETIC CAR-<br />
DIOMYOPATHY WITH A GLP-1 PEP-<br />
TIDE<br />
TRAITEMENT DU MYOCARDE HI-<br />
BERNANT ET DE LA CARDIOMIOPA-<br />
THIE DIABÉTIQUE PAR UN PEPTIDE<br />
GLP-1<br />
(71) COOLIDGE, Thomas, R. [US/US]; BioNebraska,<br />
Inc., 173 Beebe Hill Road, Falls Village,<br />
CT 06031 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) EHLERS, Mario [US/US]; Lincoln, NE<br />
(US).<br />
(74) BURROUS, Beth, A.; Foley & Lardner,<br />
Washington Harbour, 3000 K Street N.W.,<br />
Suite 500, Washington, DC 20007-5109<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/48, A61P 5/00, 15/16, 15/<strong>18</strong><br />
(11) WO 02/34286 (13) A1<br />
(21) <strong>PCT</strong>/US01/26123<br />
(22) 21 Aug/août 2001 (21.08.2001)<br />
(25) en (26) en<br />
(30) 09/692,811 20 Oct/oct 2000 US<br />
(20.10.2000)<br />
(43) 2 May/mai <strong>2002</strong> (02.05.<strong>2002</strong>)<br />
(54) METHODS FOR TREATING EN-<br />
DOCRINE DISORDERS<br />
METHODES DE TRAITEMENT DE<br />
TROUBLES ENDOCRINIENS<br />
(71) ALLERGAN SALES, INC. [US/US]; 2525<br />
Dupont Drive, Irvine, CA 92612 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DONOVAN, Stephen [CA/US]; 27252<br />
Calle Anejo, Capistrano Beach, CA 92624<br />
(US).<br />
(74) DONOVAN, Stephen et al. / etc.; c/o Allergan<br />
Sales, Inc., 2525 Dupont Drive, Irvine,<br />
CA 92612 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 39/00<br />
(11) WO 02/34287 (13) A2<br />
(21) <strong>PCT</strong>/DK01/00705<br />
(22) 26 Oct/oct 2001 (26.10.2001)<br />
(25) en (26) en<br />
(30) PA 2000 01606 27 Oct/oct 2000 DK<br />
(27.10.2000)<br />
(30) 60/245,166 3 Nov/nov 2000 US<br />
(03.11.2000)<br />
(30) PA 2001 00936 <strong>18</strong> Jun/juin 2001 DK<br />
(<strong>18</strong>.06.2001)<br />
(43) 2 May/mai <strong>2002</strong> (02.05.<strong>2002</strong>)<br />
(54) NOVEL THERAPEUTIC VACCINE<br />
FORMULATIONS<br />
NOUVELLES FORMULATIONS DE<br />
VACCIN THERAPEUTIQUE<br />
(71) PHARMEXA A/S [DK/DK]; Kogle Allé 6,<br />
DK-2970 Hørsholm (DK).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BEIER, Anne, Mette [DK/DK]; c/o<br />
Pharmexa A/S, Kogle Allé 6, DK-2970 Hørsholm<br />
(DK). GAUTAM, Anand [GB/DK];<br />
c/o Pharmexa A/S, Kogle Allé 6, DK-2970<br />
Hørsholm (DK). MOURITSEN, Søren<br />
[DK/DK]; c/o Pharmexa A/S, Kogle Allé 6,<br />
DK-2970 Hørsholm (DK).<br />
(74) KOEFOED, Peter; c/o Pharmexa A/S,<br />
Kogle Allé 6, DK-2970 Hørsholm (DK).<br />
(81) AE AG AL AM AT AT (Utility model /<br />
modèle d’utilité) AUAZBABBBGBRBY<br />
BZ CA CH CN CO CR CU CZ CZ (Utility<br />
model / modèle d’utilité) DE DE (Utility<br />
model / modèle d’utilité) DK DK (Utility<br />
model / modèle d’utilité) DMDZECEEES<br />
FI FI (Utility model / modèle d’utilité) GB<br />
GD GE GH GM HR HU ID IL IN IS JP KE<br />
KG KP KR KZ LC LK LR LS LT LU LV MA<br />
MD MG MK MN MW MX MZ NO NZ PH<br />
PL PT RO RU SD SE SG SI SK SK (Utility<br />
model / modèle d’utilité) SLTJTMTRTT<br />
TZ UA UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 39/00<br />
(11) WO 02/34288 (13) A2<br />
(21) <strong>PCT</strong>/EP01/12392<br />
(22) 24 Oct/oct 2001 (24.10.2001)<br />
(25) en (26) en<br />
(30) 0026334.3 27 Oct/oct 2000<br />
(27.10.2000)<br />
(43) 2 May/mai <strong>2002</strong> (02.05.<strong>2002</strong>)<br />
(54) VACCINE<br />
VACCIN<br />
GB